ublituximab,teriflunomide
sanofi,tg therapeutics
['ublituximab', 'multiple sclerosis', 'briumvi', 'ultimate i,(-ultimate ii)', 'tg therapeutics']
tg therapeutics announces presentation of data from the ultimate i &amp; ii phase 3 trials of briumvi (ublituximab-xiiy) in multiple sclerosis at the american academy of neurology 75th annual meeting - york, april 25, 2023 (globe newswire) -- tg therapeu... 
CEO Of Digital Media Online